PatoGen appoints Thorstein Medhus as new CEO.
PatoGen has announced the appointment of Thorstein Medhus as its new CEO, following the departure of Jørn Ulheim earlier this year. Medhus is expected to assume the role after the summer of 2025, the company said in a statement.
Medhus joins PatoGen from Wilhelmsen Chemicals, where he has served as managing director since 2013. Wilhelmsen Chemicals is one of the world’s leading producers and suppliers of marine chemicals. Prior to this, he held various roles in subsea companies. Medhus holds a cand.polit. degree from the University of Bergen.
“I am very pleased with the opportunity to lead PatoGen and look forward to building on a solid company with a strong reputation. PatoGen will continue to be a leader in fish health and contribute to the development of a sustainable aquaculture industry,” said Medhus.
PatoGen, founded in 2005, is fully owned by Fürst Medisinsk Laboratorium. The company provides laboratory services to the aquaculture industry and employs approximately 65 people across offices in Norway, Scotland, and Ireland. It specializes in fish health, diagnostics, and laboratory production, and is accredited under ISO 17025 as well as officially designated by the Norwegian Food Safety Authority.